1. What Is the Endoscopic Ultrasound Market?
The Endoscopic Ultrasound Market comprises endoscopic systems that combine conventional endoscope optics with an ultrasound transducer at the endoscope tip for imaging structures adjacent to the gastrointestinal tract. The market includes linear array EUS endoscopes, radial array EUS scopes, EUS-guided fine needle aspiration accessories, EUS-guided therapeutic devices, and processor units. These systems serve gastroenterologists, hepatologists, and pancreatologists performing staging of pancreatic and gastrointestinal cancers, celiac plexus interventions, and EUS-guided therapeutic drainage. The scope excludes standard upper and lower gastrointestinal endoscopes without ultrasound capability, external abdominal ultrasound for GI assessment, and ERCP-guided procedures without ultrasound integration.
2. Endoscopic Ultrasound Market Size & Forecast
3. Emerging Technologies
- Through-the-needle EUS confocal endomicroscopy is advancing to provide real-time cellular-level imaging during cyst aspiration without additional endoscope insertion. Growing clinical use of needle-based confocal microscopy is improving accuracy of benign versus malignant pancreatic cyst differentiation during EUS-guided sampling.
- Contrast-enhanced EUS using microbubble agents is advancing to improve vascularity assessment of pancreatic lesions and lymph nodes during real-time endosonography. Increasing adoption of contrast EUS is improving differentiation of hypervascular tumors and guiding FNB needle placement toward viable tumor tissue.
- Radiofrequency ablation probes for EUS-guided delivery are advancing for pancreatic tumor and pancreatic cyst treatment without surgical resection. Continued development of EUS-RFA enables minimally invasive treatment of T1 pancreatic neoplasms and ablation of refractory high-risk cysts.
- Digital single-use EUS endoscopes are advancing to reduce infection transmission risk and eliminate reprocessing cost between linear array EUS procedures. Expanding disposable EUS adoption is improving infection control compliance and reducing total procedural cost at high-volume EUS programs.
Such innovations are driving change across adjacent industries too. Discover more in our Magnetic Resonance Imaging Mri Contrast Agent Market.
4. Key Market Opportunity
One of the major opportunities in the Endoscopic Ultrasound Market is the development of EUS-guided molecular profiling workflows that combine EUS-FNB sampling with real-time biomarker analysis for pancreatic cancer diagnosis and treatment selection in a single endoscopy session. Pancreatic cancer patients currently require multiple procedures for tissue diagnosis, biomarker profiling, and treatment decision, creating delays that affect outcomes in an aggressive malignancy. Advances in rapid on-site evaluation, liquid biopsy from EUS-FNA aspirate, and integrated molecular testing workflows are enabling same-session tissue diagnosis and treatment guidance. Endoscopy platform developers integrating molecular testing into EUS biopsy workflows stand to improve time from EUS to treatment initiation for pancreatic cancer patients.
5. Top Companies in the Endoscopic Ultrasound Market
The following organisations hold leading positions in the Endoscopic Ultrasound Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Olympus
- FUJIFILM
- Pentax Medical (HOYA)
- Boston Scientific
- Cook Medical
- Medtronic
- Medi-Globe
- Endoscopy Solutions
- Steris
- Conmed
- Endo-Therapeutics
- Micro-Tech Endoscopy
6. Market Segmentation
The Endoscopic Ultrasound Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By System Type | Linear Array EUS Scope Curved Linear EUS Radial Array EUS Scope EUS Miniprobe Disposable EUS Endoscope |
| By Application | Pancreatic Cancer Staging Pancreatic Cyst Evaluation Biliary Stricture Assessment Mediastinal Lymph Node Sampling Celiac Plexus Neurolysis EUS-Guided Drainage |
| By Guidance Type | Diagnostic FNA Sampling Core Biopsy FNB Sampling EUS-Guided Therapeutic EUS Elastography |
| By Setting | Tertiary Academic Medical Center Community Gastroenterology Practice Pancreatic Disease Specialty Program |
| By End User | Interventional Gastroenterologists Hepatopancreatobiliary Surgeons Endoscopic Oncology Programs Academic Gastroenterology Centers |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Endoscopic Ultrasound Market trajectory over the forecast period:
EUS-Guided Fine Needle Biopsy Is Replacing Fine Needle Aspiration for Core Histological Sampling.Gastroenterologists are adopting fork-tip and forward-bevel fine needle biopsy devices that retrieve tissue cores for histological analysis rather than cytology samples from fine needle aspiration. Boston Scientific advanced its Acquire EUS-FNB needle and Axios hot stent drainage system in 2024, expanding procedural capability for pancreatic cyst drainage and transgastric biliary access.
EUS-Guided Therapeutic Drainage Is Expanding the Role of Endoscopy in Pancreatobiliary Disease.Gastroenterologists are performing EUS-guided cystgastrostomy, biliary drainage, and pancreatic duct access as endoscopic alternatives to surgical and percutaneous drainage procedures. Olympus advanced its GF-UCT190 linear array therapeutic EUS scope in 2024, improving working channel capacity and instrument compatibility for EUS-guided drainage and lumen-apposing stent placement.
Artificial Intelligence EUS Image Analysis Is Improving Pancreatic Lesion Characterization.Endoscopists are using AI-assisted EUS image analysis software to improve discrimination between pancreatic adenocarcinoma, neuroendocrine tumors, and benign cysts during real-time examination. FUJIFILM advanced its CAD EYE AI-assisted endoscopy and EUS characterization software in 2024, improving automated lesion detection and risk stratification for pancreatic EUS programs.
For related market intelligence, see the Magnetic Resonance Imaging Mri Scanner Market.
8. Segmental Analysis
By System Type, linear array EUS scope dominated the Endoscopic Ultrasound Market in 2025, driven by its therapeutic channel capability for guided biopsy and intervention. Gastroenterologists continue specifying linear EUS owing to the working channel enabling FNA, FNB, and therapeutic accessory deployment during real-time imaging. Disposable EUS endoscope is the fastest-growing System Type category, driven by infection control requirements and reprocessing cost reduction at high-volume endoscopy programs. Endoscopy units are advancing disposable EUS adoption as single-use endoscope availability improves and regulatory guidance on endoscope infection risk supports disposal.
By Application, pancreatic cancer staging dominated the Endoscopic Ultrasound Market in 2025, reflecting the primary clinical indication driving EUS adoption at academic and community programs. Gastroenterologists continue directing EUS use toward pancreatic staging owing to EUS superiority over CT for T-stage assessment in localized pancreatic adenocarcinoma. EUS-guided drainage is the fastest-growing Application category, driven by gastroenterologists adopting lumen-apposing metal stents for pancreatic pseudocyst and biliary drainage. Gastroenterologists are advancing therapeutic EUS as lumen-apposing stents enable transmural drainage with lower perforation risk than conventional cystenterostomy techniques.
9. Regional Analysis
Regional demand patterns across the Endoscopic Ultrasound Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Endoscopic Ultrasound Market in 2025, holding 44.6% of the global market. Largest academic medical center EUS program concentration, high pancreatic cancer incidence, and established gastroenterology subspecialty training infrastructure anchor North American EUS revenue. US academic medical centers and tertiary gastroenterology programs are the primary adopters of advanced EUS therapeutic platforms and AI-assisted lesion characterization systems. Strong gastroenterologist training in EUS at academic fellowship programs and high endoscopy procedure volumes sustain consistent EUS scope and accessory utilization.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 16.20% during the forecast period. High gastric and pancreatic cancer incidence in Japan, China, South Korea, and Singapore drives growing EUS staging and sampling volumes at established gastrointestinal oncology centers. Japanese gastroenterology EUS leadership in pancreatic disease and biliary interventions is contributing clinical evidence that influences global EUS practice guidelines. Expanding gastroenterology training programs and growing therapeutic EUS volume at regional cancer centers are increasing EUS system and accessory demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Endoscopic Ultrasound Market was valued at USD 1.28 Bn in 2025 and is projected to reach USD 3.34 Bn by 2034, growing at a CAGR of 11.20% over the 2026–2034 forecast period.
The Endoscopic Ultrasound Market is projected to grow at a CAGR of 11.20% from 2026 to 2034.
North America accounted for the largest share of the Endoscopic Ultrasound Market in 2025, holding 44.6% of the global market.
The leading companies in the Endoscopic Ultrasound Market include Olympus, FUJIFILM, Pentax Medical (HOYA), Boston Scientific, Cook Medical, Medtronic, Medi-Globe, Endoscopy Solutions, Steris, Conmed, Endo-Therapeutics, Micro-Tech Endoscopy.
Eus-guided fine needle biopsy is replacing fine needle aspiration for core histological sampling.
By System Type, linear array EUS scope dominated the Endoscopic Ultrasound Market in 2025, driven by its therapeutic channel capability for guided biopsy and intervention.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.